Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PABIR family member 3 is a protein conserved across multiple vertebrate species, orthologous to the mouse Pabir3 gene[3][4]. Functional annotations suggest roles in basic cellular processes, with predicted protein binding capability and possible function as a protein serine/threonine phosphatase inhibitor[3][5]. There is no evidence from current gene function resources or experimental databases that it acts as a classical drug target (receptor, enzyme, transporter, etc.), nor is it associated with any specific pathologies or therapeutic interventions. Expression data are limited and do not indicate restriction to any specific tissue or disease state[7]. Research into this protein and the PABIR family overall remains preliminary. Limitations: Current data are insufficient to categorize PABIR3 as a therapeutic target, associate it with established disease mechanisms, or support the existence of interacting small molecules or drugs[3][5][7]. If you require structured details on more established or characterized targets, consider reviewing gene or protein entries with functional validation in reference databases such as UniProt, GeneCards, or the Human Protein Atlas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PABIR family member 3 (PABIR3).